✦ LIBER ✦

Pharmacological validation of a novel animal model of anticipatory anxiety in mice

✍ Scribed by Alessandro Lecci; Franco Borsini; Giovanna Volterra; Alberto Meli

Publisher: Springer
Year: 1990
Tongue: English
Weight: 856 KB
Volume: 101
Category: Article
ISSN: 0033-3158
DOI: 10.1007/bf02244136

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Pharmacological validation of a new anim

Pharmacological validation of a new animal model of alcoholism

✍ R. Spanagel; S. M. Hölter 📂 Article 📅 2000 🏛 Springer 🌐 English ⚖ 178 KB

The validity of scopolamine as a pharmac

The validity of scopolamine as a pharmacological model for cognitive impairment: A review of animal behavioral studies

✍ Inge Klinkenberg; Arjan Blokland 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 1008 KB

Scopolamine is used as a standard/reference drug for inducing cognitive deficits in healthy humans and animals. Effects are often interpreted in terms of a role of acetylcholine in mnemonic and/or attentional processes. In this paper an overview is given of the effects of scopolamine on animal behav

Behavioural and pharmacological characte

Behavioural and pharmacological characterisation of the canopy stretched attend posture test as a model of anxiety in mice and rats

✍ S. S Grewal; J. K. Shepherd; David J. Bill; A. Fletcher; C. T. Dourish 📂 Article 📅 1997 🏛 Springer 🌐 English ⚖ 740 KB

The stress-induced hyperthermia paradigm

The stress-induced hyperthermia paradigm as a physiological animal model for anxiety: A review of pharmacological and genetic studies in the mouse

✍ J. Adriaan Bouwknecht; Berend Olivier; Richard E. Paylor 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 589 KB

Enhanced fear expression in a psychphath

Enhanced fear expression in a psychphathological mouse model of trait anxiety: pharmacological interventions

✍ Markus Hauschild; Simone B Sartori; Mirjam Bunck; Stefano Gaburro; Rainer Landgr 📂 Article 📅 2010 🏛 BioMed Central 🌐 English ⚖ 131 KB

PHNO, a novel dopamine agonist, in anima

PHNO, a novel dopamine agonist, in animal models of parkinsonism

✍ Dr. William Koller; Gregory Herbster; John Gordon 📂 Article 📅 1987 🏛 John Wiley and Sons 🌐 English ⚖ 347 KB

PHNO, a naphthoxazine compound, was investigated in animal models of central dopaminergic activity. The drug in doses of 5-300 micrograms/kg when administered subcutaneously, or transdermally, induced stereotypic behavior in rats which was blocked by haloperidol but not by reserpine pretreatment. In